Mill Creek Life Sciences announces receipt of a grant during the inaugural round of funding from Regenerative Medicine Minnesota.
News and Updates
Featured Article
Feb 07 2020
“Based on promising results in an early clinical trial, Mayo Clinic has formed a new joint venture with materials engineering firm W.L. Gore & Associates to spearhead a new therapy using stem cells to repair a painful tissue problem stemming from Crohn's disease.”
Jun 18 2019
Mill Creek Life Sciences, LLC (Mill Creek), a Rochester, MN based start-up that supports the development and application of cellular and biological therapeutics, has received a one-year $100,000 grant from Regenerative Medicine Minnesota (RMM) titled: "Development of Technology for the Large-scale Production of a Novel Dendritic Cell Vaccine for the Treatment of Glioblastoma."
Nov 08 2018
Mill Creek Life Sciences, LLC (Mill Creek), a Rochester, MN based start-up that provides tools to support the development and application of cellular and biological therapeutics, is pleased to announce they have been certified under ISO 9001:2015 by DNV GL, effective September 10, 2018.
Press Releases
Aug 18 2015
Sep 14 2011
With favorable regenerative and immunotolerant profiles, patient-derived human mesenchymal stem cells (hMSCs) are increasingly considered in cell therapy.
- Prev
- 2 of 2
Contact
Available from these distributors!
Research grade PLTMax® and PLTGold® are available from LAgen Laboratories in the 100mL bottle size.